News

Partner companies' news

Ideanomics to Speak on Three Panels at BloombergNEF Summit in San Francisco
SAN FRANCISCO, Jan. 26, 2022 /PRNewswire/ -- Ideanomics [1]  (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of el...
Acorn Management Partners, Administrator
— January 2022 — 679 views IDEX

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
SAN JOSE, Calif., Jan. 25, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1]  (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— January 2022 — 676 views ANIX

Anixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease Inhibitor
SAN JOSE, Calif. and STUTTGART, Germany, Jan. 24, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1]  (NASDAQ: ANIX), a biotechnology company focuse...
Acorn Management Partners, Administrator
— January 2022 — 582 views ANIX

KemPharm Issues Letter to Shareholders Detailing Strategic Focus on CNS/Rare Disease Indications and Updated Clinical Development Strategy
CELEBRATION, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 559 views KMPH

Foresight and SUNWAY-AI Collaborate to Commercialize Autonomous Technologies to the Chinese Agriculture Market
--News Direct-- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight”), an innovator in automotive vision systems, announced today...
Acorn Management Partners, Administrator
— January 2022 — 550 views FRSX

KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion
CELEBRATION, Fla., Jan. 12, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 588 views KMPH

KemPharm Announces Research Involving Serdexmethylphenidate to be Featured in Two Poster Presentations at the APSARD 2022 Annual Conference
CELEBRATION, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 555 views KMPH

Foresight: Eye-Net Enters Indian Market with Pilot Project for Fleet Telematics
--News Direct-- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its whol...
Acorn Management Partners, Administrator
— January 2022 — 593 views FRSX

Luokung Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
BEIJING, Jan. 7, 2022 /PRNewswire*/ *--* Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intellig...
Acorn Management Partners, Administrator
— January 2022 — 560 views LKCO

Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
FRAMINGHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“*Arch*” or the “*Company*”), a marketer and developer o...
Acorn Management Partners, Administrator
— January 2022 — 570 views ARTH

KemPharm to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2022”
CELEBRATION, Fla., Jan. 06, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 564 views KMPH

Foresight Expands Chinese Market Presence with Establishment of Local Subsidiary
--News Direct-- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), (“Foresight” or the “Company”), an innovator in automotive vision system...
Acorn Management Partners, Administrator
— January 2022 — 723 views FRSX

Arch Therapeutics Announces Appointment of Guy Fish to the Board
FRAMINGHAM, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“*Arch*” or the “*Company*”), a marketer and developer o...
Acorn Management Partners, Administrator
— January 2022 — 655 views ARTH

Ideanomics Announces Strategic Investment with InoBat to Collaborate on EV Battery Offerings
NEW YORK, Jan. 4, 2022 /PRNewswire/ -- Ideanomics [1]  (NASDAQ: IDEX), a global company that accelerates the commercial adoption of electric vehicl...
Acorn Management Partners, Administrator
— January 2022 — 524 views IDEX

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives